UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

The Lancet (British edition), 2011-07, Vol.378 (9787), p.279-281

2011

Volltextzugriff (PDF)

A mechanism‐based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID‐19 treatment in humans

CPT: pharmacometrics and systems pharmacology, 2021-02, Vol.10 (2), p.89-99

2021

Volltextzugriff (PDF)

Bottlenecks in HIV-1 transmission: insights from the study of founder viruses

Nature reviews. Microbiology, 2015-07, Vol.13 (7), p.414-425

2015

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System

Clinical pharmacokinetics, 2018-09, Vol.57 (9), p.1059-1074

2018

Volltextzugriff (PDF)

Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization

Analytical and bioanalytical chemistry, 2015-03, Vol.407 (8), p.2073-2084

2015

Volltextzugriff (PDF)

Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry Imaging of Human Hair to Characterize Longitudinal Profiles of the Antiretroviral Maraviroc for Adherence Monitoring

Analytical chemistry (Washington), 2019-08, Vol.91 (16), p.10816-10822

2019

Volltextzugriff (PDF)

Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirs

Antimicrobial agents and chemotherapy, 2015-05, Vol.59 (5), p.2944-2948

2015

Volltextzugriff (PDF)

A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood Spots

Clinical pharmacology and therapeutics, 2023-04, Vol.113 (4), p.896-903

2023

Volltextzugriff (PDF)

Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness

Journal of acquired immune deficiency syndromes (1999), 2015-07, Vol.69 (3), p.264-269

2015

Volltextzugriff (PDF)

HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities

AIDS research and human retroviruses, 2017-06, Vol.33 (6), p.513-523

2017

Volltextzugriff (PDF)

Analysis of Antiretrovirals in Single Hair Strands for Evaluation of Drug Adherence with Infrared-Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry Imaging

Analytical chemistry (Washington), 2016-01, Vol.88 (2), p.1336-1344

2016

Volltextzugriff (PDF)

Antiretroviral concentrations and surrogate measures of efficacy in the brain tissue and CSF of preclinical species

Xenobiotica, 2019-10, Vol.49 (10), p.1192-1201

2019

Volltextzugriff (PDF)

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Journal of pharmaceutical and biomedical analysis, 2022-10, Vol.220, p.115010-115010, Article 115010

2022

Volltextzugriff (PDF)

Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials

AIDS and behavior, 2015-05, Vol.19 (5), p.743-751

2015

Volltextzugriff (PDF)

The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue

AIDS (London), 2018-01, Vol.32 (1), p.11-15

2018

Volltextzugriff (PDF)

HIV pre-exposure prophylaxis: Mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model

Virology (New York, N.Y.), 2014-09, Vol.464, p.253-263

2014

Volltextzugriff (PDF)

Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients

Journal of clinical pharmacology, 2022-12, Vol.62 (12), p.1518-1527

2022

Volltextzugriff (PDF)

Validation of an LC–MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots

Journal of pharmaceutical and biomedical analysis, 2018-02, Vol.149, p.40-45

2018

Volltextzugriff (PDF)

Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection

World journal of hepatology, 2016-03, Vol.8 (7), p.368-375

2016

Volltextzugriff (PDF)

Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users

Journal of acquired immune deficiency syndromes (1999), 2019-01, Vol.80 (1), p.79-88

2019

Volltextzugriff (PDF)

Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial

JMIR mHealth and uHealth, 2018-09, Vol.6 (9), p.e10456-e10456

2018

Volltextzugriff (PDF)

Pre-exposure prophylaxis for HIV prevention: how to predict success

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2409-2411

2012

Volltextzugriff (PDF)

Antiretroviral drug exposure in the female genital tract : implications for oral pre-and post-exposure prophylaxis

AIDS (London), 2007-09, Vol.21 (14), p.1899-1907

2007

Volltextzugriff (PDF)

Kaletra (lopinavir/ritonavir)

The Annals of pharmacotherapy, 2002-07, Vol.36 (7-8), p.1193-1203

2002

Volltextzugriff (PDF)

S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults

European journal of clinical pharmacology, 2021-09, Vol.77 (9), p.1349-1356

2021

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(65)
Humans
(61)
Female
(43)
Human Immunodeficiency Virus
(37)
Pharmacology & Pharmacy
(33)
Adult
(32)
Infectious Diseases
(30)
Male
(29)
Hiv
(28)
Virology
(22)
Hiv Infections - Drug Therapy
(21)
Pharmacokinetics
(20)
Immunology
(19)
Anti-Hiv Agents - Pharmacokinetics
(18)
Biological And Medical Sciences
(16)
Hiv Infections - Prevention & Control
(16)
Medical Sciences
(16)
Antiretroviral Drugs
(15)
Middle Aged
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

A mechanism‐based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID‐19 treatment in humans

Bottlenecks in HIV-1 transmission: insights from the study of founder viruses

Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System

Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization

Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry Imaging of Human Hair to Characterize Longitudinal Profiles of the Antiretroviral Maraviroc for Adherence Monitoring

Mass spectrometry imaging reveals heterogeneous efavirenz distribution within putative HIV reservoirs

A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood Spots

Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness

HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities

Analysis of Antiretrovirals in Single Hair Strands for Evaluation of Drug Adherence with Infrared-Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry Imaging

Antiretroviral concentrations and surrogate measures of efficacy in the brain tissue and CSF of preclinical species

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials

The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue

HIV pre-exposure prophylaxis: Mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model

Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients

Validation of an LC–MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots

Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection

Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users

Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial

Pre-exposure prophylaxis for HIV prevention: how to predict success

Antiretroviral drug exposure in the female genital tract : implications for oral pre-and post-exposure prophylaxis

Kaletra (lopinavir/ritonavir)

S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults

Suchergebnisse filtern